William Lehmann - Athersys President COO
President
Mr. William B.J. Lehmann, Jr. J.D., is President and Chief Operating Officer of Athersys Inc. Mr. Lehmann joined Athersys in September 2001 and has served as our President and Chief Operating Officer since June 2006. Prior to that time, Mr. Lehmann was Athersys Executive Vice President of Corporationrationrate Development and Finance from August 2002 until June 2006, when he became Athersys President and Chief Operating Officer. From 1994 to 2001, Mr. Lehmann was with McKinsey Company, Inc., or McKinsey, an international management consulting firm, where he worked extensively with new technology and servicebased businesses in a variety of industries. Prior to joining McKinsey, he worked at Wilson, Sonsini, Goodrich Rosati, a Silicon Valley law firm, and worked with First Chicago Corporationrationration, a financial institution since 2006.
| Age | 52 |
| Tenure | 18 years |
| Professional Marks | MBA |
| Phone | 216 431-9900 |
| Web | www.athersys.com |
Athersys Management Efficiency
The company has return on total asset (ROA) of (1.0409) % which means that it has lost $1.0409 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7602) %, meaning that it created substantial loss on money invested by shareholders. Athersys' management efficiency ratios could be used to measure how well Athersys manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 9.43 M in liabilities. Athersys has a current ratio of 0.53, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Athersys until it has trouble settling it off, either with new capital or with free cash flow. So, Athersys' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Athersys sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Athersys to invest in growth at high rates of return. When we think about Athersys' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michel Dahan | Akebia Ther | 45 | |
| Karen Tubridy | Akebia Ther | 55 | |
| John Limongelli | Trevena | 47 | |
| Mark Rosch | Akebia Ther | N/A | |
| Ramin FarzanehFar | Akebia Ther | N/A | |
| Thomas Meyer | Altamira Therapeutics | 56 | |
| Robert Yoder | Trevena | 58 | |
| Bradley Maroni | Akebia Ther | N/A | |
| Steven Burke | Akebia Ther | 63 | |
| Roberto Cuca | Trevena | 48 | |
| Yacoub Habib | Trevena | 49 | |
| Dell Faulkingham | Akebia Ther | N/A | |
| Lucy Lu | Fortress Biotech | 39 | |
| Carrie Bourdow | Trevena | 61 | |
| Rita Jain | Akebia Ther | 55 | |
| Ed Joyce | Akebia Ther | N/A | |
| David Soergel | Trevena | 48 | |
| Theresa McNeely | Akebia Ther | N/A | |
| Robert Lisicki | Zura Bio Limited | 56 | |
| Mark Demitrack | Trevena | 66 | |
| Brad Maroni | Akebia Ther | N/A | |
Management Performance
| Return On Equity | -12.76 | |||
| Return On Asset | -1.04 |
Athersys Leadership Team
Elected by the shareholders, the Athersys' board of directors comprises two types of representatives: Athersys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Athersys. The board's role is to monitor Athersys' management team and ensure that shareholders' interests are well served. Athersys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Athersys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kasey Rosado, Interim Officer | ||
| Ellen Gurley, Mang Relations | ||
| Lorin Randall, Independent Director | ||
| Kenneth Traub, Independent Director | ||
| Robert Deans, Executive VP of Regenerative Medicine | ||
| Lee Babiss, Independent Director | ||
| William Lehmann, President COO | ||
| MBA MD, Ex Affairs | ||
| Robert Mays, Head VP | ||
| Daniel MBA, Sec, CEO | ||
| Ismail Kola, Independent Director | ||
| MS MBA, Chief Officer | ||
| Alison MBA, VP HR | ||
| Gil Bokkelen, Co-Founder, Chairman and CEO | ||
| John Harrington, Co-Founder, Chief Scientific Officer, Executive VP and Director | ||
| Jack Wyszomierski, Independent Director | ||
| PMP BS, Ex Manufacturing | ||
| Laura Campbell, Vice President - Finance | ||
| Jordan Davis, Independent Director | ||
| Rakesh MS, Head VP |
Athersys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Athersys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.76 | |||
| Return On Asset | -1.04 | |||
| Operating Margin | (260.55) % | |||
| Current Valuation | 24.52 M | |||
| Shares Outstanding | 26.71 M | |||
| Shares Owned By Insiders | 0.50 % | |||
| Shares Owned By Institutions | 11.30 % | |||
| Number Of Shares Shorted | 993.2 K | |||
| Price To Earning | 0.39 X | |||
| Price To Book | 219.57 X |
Pair Trading with Athersys
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Athersys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Athersys will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Athersys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Athersys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Athersys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Athersys to buy it.
The correlation of Athersys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Athersys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Athersys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Athersys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Athersys information on this page should be used as a complementary analysis to other Athersys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Athersys Pink Sheet
If you are still planning to invest in Athersys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athersys' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |